The Goods and Services Tax Council after its 50th meet in New Delhi on Tuesday has agreed to exempt GST on import of cancer drug Dinutuximab, and Food for Special Medical Purposes (FSMP) used in the treatment of rare diseases. Currently, the drug attracts a 12% integrated GST.
Recent Posts
- Govt drops any merger plans among PSU general insurers
- Trump says US to start blockading the Strait of Hormuz immediately
- US-Iran peace talks end without a deal as delegations leave Pakistan
- State can’t differentiate between serving employees and pensioners on DA: SC
- Rajive Kumaraswami to succeed V. Suryanarayanan as MD & CEO of Chola MS
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits